Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Correction: Calcium electroporation for treatment of sarcoma in preclinical studies

    Research output: Contribution to journalJournal articleResearch

  3. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The efficacy of topical agents used in wounds for managing chronic biofilm infections: A systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The environmental occurrence of Pseudomonas aeruginosa

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer

    Research output: Contribution to journalReviewResearchpeer-review

  5. Biofilms of Mycobacterium abscessus complex can be sensitized to antibiotics by disaggregation and oxygenation

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Anti-microbial peptides are produced at outer and inner surfaces by epithelia and innate immune cells in response to bacterial infection. Staphylococcus aureus is an enterotoxin producing, Gram-positive pathogen, which is a major cause of soft tissue infections and life-threatening bacteremia and sepsis. Here we show that (i) skin T cells in chronic wounds infected with S. aureus express interleukin-26 (IL-26) in situ, (ii) staphylococcal enterotoxins (SE) trigger IL-26 expression in T cell lines and primary skin T cells, and (iii) IL-26 triggers death and inhibits biofilm formation and growth of S. aureus. Thus, we provide novel evidence that IL-26 is an anti-microbial peptide produced by T cells in response to SE. Accordingly, we propose that IL-26 producing T cells take part in the innate immune response to SE producing S. aureus and thus play a novel role in the primary innate immune defense in addition to their classical role in adaptive immunity.

Original languageEnglish
JournalOncotarget
Volume9
Issue number28
Pages (from-to)19481-19489
Number of pages9
ISSN1949-2553
DOIs
Publication statusPublished - 13 Apr 2018

ID: 55803472